Hanhai New Enzyme Biotechnology has developed hundreds of biopharmaceutical and vaccine production related raw materials based on technology platforms such as enzyme gene mining and performance characterization, enzyme molecule optimization and modification, high-throughput screening of enzyme genes, organic synthesis, synthetic biology, antigen antibody research and development, etc. It can provide customers with a complete set of enzyme raw materials, various T7 RNA polymerase mutants, chemical substrates, cap analogues, etc. required for mRNA drug and vaccine production. The company has established a pharmaceutical grade special enzyme production system with a super large production scale and ultra-high equipment standards, and has provided products and services to over 100 domestic biopharmaceutical, vaccine preparation, and in vitro diagnostic reagent manufacturers; At the same time, the products are exported to 25 countries and regions overseas.

Hanhai New Enzyme Shanghai R&D Center is located at Hanhai Building, 3006 Huancheng West Road, Shanghai. The 12000 square meter headquarters building is equipped with high standard laboratories and a professional R&D team. It can provide a complete set of solutions for mRNA vaccines and drugs based on raw materials, including IVT process development, mRNA purification process development, and LNP preparation process development. And we have launched mRNA vaccine and drug concept validation services, mRNA and LNP customized synthesis services, and mRNA third-party quality inspection services tailored to customers' application scenarios and personalized needs, to assist customers in the research and development of mRNA vaccine drugs and provide comprehensive product development support for customers.